Literature DB >> 207906

Simultaneous serum and CSF antibodies in herpes simplex virus encephalitis.

D P Levine, C B Lauter, A M Lerner.   

Abstract

Serial concomitant paired sera (S) and CSF were taken from eight patients with biopsy-proved herpes simplex virus encephalitis (HSVE). These specimen pairs were compared with 28 others from patients with various neurologic conditions. Before and after reduction with 2-mercaptoethanol, a ratio of S/CSF antibody titers of less than or equal to 20 with either the passive hemagglutinating (PHA) or immune adherence hemagglutinating (IAHA) antibody tests occurred in every patient with HSVE. Diagnostic S/CSF ratios were noted in three patients before biopsy of the brain and in four patients by the tenth day of neurologic disease. Among control subjects, a ratio of S/CSF titers greater than 20 was observed in all but four patients. Each of the latter patients had neurologic diagnoses easily distinguishable from HSVE. The PHA or IAHA S/CSF ratio offers a rapid, reliable method for the diagnosis of HSVE (P less than .001).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207906

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  17 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.

Authors:  K J Champney; C B Lauter; E J Bailey; A M Lerner
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

3.  Non-invasive method for early diagnosis of herpes simplex encephalitis.

Authors:  N Hanada; S Kido; M Terashima; K Nishikawa; T Morishima
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

4.  Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy.

Authors:  W M Wenman; J L Brunton; B A Lank; A R Ronald
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

5.  Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro.

Authors:  M J Gill; J Samuel; L I Wiebe; E E Knaus; D L Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Anti-herpes simplex type 1 activity in IgG subclasses produced systemically and intrathecally in patients with herpes encephalitis.

Authors:  P J Johansson; J Blomberg
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

7.  Diagnosis of herpes simplex virus encephalitis by detection of virus-specific immunoglobulins A and G in serum and cerebrospinal fluid by using an antibody-capture enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; B Postma; M F Peeters
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

8.  Detection of viral antigens in cerebrospinal fluid of rabbits with experimental herpes simplex virus type 1 encephalitis.

Authors:  C A Bos; J B Wilterdink; A J Scheffer
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid.

Authors:  D S Burke; A Nisalak; M A Ussery
Journal:  J Clin Microbiol       Date:  1982-12       Impact factor: 5.948

10.  Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis.

Authors:  M L Koskiniemi; A Vaheri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.